Can Preoperative C-Reactive Protein Predict Bleeding After On-Pump Coronary Artery Bypass Grafting?

Xiaojie Liu1, Wenyuan Zhang2, Naping Chen3

  • 1Department of Anesthesiology, State Key Laboratory of Cardiovascular Disease, National Clinical Research Center of Cardiovascular Diseases, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Insights

Elevated preoperative C-reactive protein (CRP) levels independently predict increased postoperative bleeding in patients undergoing coronary artery bypass grafting (CABG). This finding suggests CRP may serve as a novel biomarker for predicting bleeding risk after CABG surgery.

Area of Science:

  • Cardiology
  • Biomarkers
  • Surgical Outcomes

Background:

  • Postoperative bleeding is a significant complication following cardiac surgery.
  • Elevated C-reactive protein (CRP) is linked to cardiovascular risk.
  • Limited data exists on the association between preoperative CRP and bleeding after coronary artery bypass grafting (CABG).

Purpose of the Study:

  • To investigate the relationship between preoperative C-reactive protein (CRP) levels and postoperative bleeding within 24 hours after on-pump coronary artery bypass grafting (CABG).

Main Methods:

  • A cohort of 1055 patients undergoing isolated primary CABG was analyzed.
  • Preoperative CRP, coagulation parameters, and intraoperative data were recorded.
  • Postoperative bleeding volume within 24 hours was the primary endpoint, analyzed using regression models.

Main Results:

  • Preoperative CRP concentration was univariably correlated with postoperative bleeding volume.
  • Multiple linear regression identified preoperative CRP as an independent predictor of postoperative bleeding (B = -0.089, P < .05).
  • CRP also showed associations with body mass index, activated partial thromboplastin time, and fibrinogen.

Conclusions:

  • Preoperative CRP concentration is an independent predictor of postoperative bleeding within 24 hours after CABG.
  • CRP may represent a novel coagulation biomarker for assessing bleeding risk in CABG patients.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
903
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
380
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
218
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
332
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
596
Bleeding in Fresh Concrete01:22

Bleeding in Fresh Concrete

Bleeding in fresh concrete occurs when water from the mix rises to the surface. This happens because the mix's solid components fail to retain all the water as they settle, leading to separation where water collects at the top. The severity of bleeding can be measured by assessing the total settlement or by noting the decrease in height per unit height of concrete.
Bleeding can cause several issues in the concrete structure. Sometimes, the rising water gets trapped beneath large aggregate...
547